| Tag | Content |
|---|
EnhancerAtlas ID | HS060-20129 |
Organism | Homo sapiens |
Tissue/cell | GM12891 |
Coordinate | chr2:136996170-136996950 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| SPI1 | MA0080.4 | chr2:136996513-136996527 | CACTTCCTGTTTTT | - | 6.36 |
|
| | Number of super-enhancer constituents: 7 | ID | Coordinate | Tissue/cell |
| SE_09631 | chr2:136994962-136998523 | CD14 | | SE_10274 | chr2:136994079-136998605 | CD19_Primary | | SE_11065 | chr2:136993029-137000475 | CD20 | | SE_35084 | chr2:136991573-136998521 | HeLa | | SE_39801 | chr2:136995254-136997355 | Jurkat | | SE_61425 | chr2:136945577-137039880 | Toledo | | SE_62403 | chr2:136962507-137014815 | Tonsil |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I136235 | chr2 | 136993037 | 136998458 |
|
Enhancer Sequence | GGGCCAGAGA TTTTCTTTCA GGAGCTAAAT CCCAGGGCTT AGTAATGGTA TTTGGCCTTA 60
AGCCTGCAAA TGGCACTTTC ATCCAGCAAT ATAAGCCCTG AAGTTTTTCT CAGCTGCAGA 120
GAAGAGGTTT CCAGGAGGGT GTCAGTTTGG CCCTTGCTGG TGGCCTGGCC TCTGCTAAAC 180
ATCTCGGCCG TGCTCCTCCA TTTTCTGGCC GTGATAAGGC ACCCCGCCAA GCATATCTCA 240
GACAAATATC TGTATTGTTT GTGGTGTGAT TGTGACTTCC TGTCTTCCAA TTTAGTTTTC 300
TGCCTTACTT TTCACTGTCT GGGTCATTTG ATACTACATC TGGCACTTCC TGTTTTTTAA 360
GACTCTGACT CTAGTCATCT GACTGTAGAA AACAGAGGTC AACTTCTTCA TAAGTGATGC 420
CAGCTTTAGT CACTTGTTTT GGTATACTAG TTGAGATTTG CGTAAGGAAA ATTGTCAGGT 480
GTCTGCTGGT TTTCTTAGCC TCAGACACTT CCCTATTTAT AAGTTTTTGT TTTTCAGACA 540
TTGGGACTTT CTCCCCCTTG TGTGGATGTG GTGGGAGTGG GTGATCTCTG CCCTGTCCCT 600
ACAAATAATT CAACGGTGGT TCTCTCTCTC TTAAGGAGAA CTACCAGTCC CGTAGATGCA 660
GCTCTAGAAT GAGGGTGCTT TGGGCATAAC AGGCTCAGCC ATCCTTCTGG TGTCTCGCCC 720
TGTCTCCTTT CCCATCCTTG GGTTCACTTC TCTCCCTTTT TCTCTTCACT TCAAAAGTGG 780
|
